SEGMENT AND RELATED INFORMATION

12 Months Ended

Jun. 30, 2022

Segment Reporting [Abstract]

SEGMENT AND RELATED INFORMATION

NOTE 17 - SEGMENT AND RELATED INFORMATION

The Company provides segment data in accordance with the provisions of ASC topic 280, “Disclosures about Segments of an Enterprise and Related Information”.

The Company operates in two industry segments - manufacturing and the servicing of medical equipment and management of diagnostic imaging centers.

The accounting policies of the segments are the same as those described in the summary of significant accounting policies. All intersegment sales are market-based. The Company evaluates performance based on income or loss from operations.

Summarized financial information concerning the Company’s reportable segments is shown in the following table:

Summarized Segment Financial Information

	Manufacturing and Servicing of Medical			Management of Diagnostic Imaging
Fiscal 2022:	Equipment			Center		Totals
Net revenues from external customers	$	8,218,804		$	89,373,341	$	97,592,145
Intersegment net revenues *	$	965,417		$	—	$	965,417
(Loss) Income from operations	$	(4,604,305	)	$	26,611,487	$	22,007,182
Depreciation and amortization	$	263,559		$	4,271,677	$	4,535,236
Compensatory element of stock issuances	$	—		$	—	$	—
Total identifiable assets	$	10,259,937		$	189,082,045	$	199,341,982
Capital expenditures	$	258,271		$	4,374,903	$	4,633,174
Fiscal 2021:
Net revenues from external customers	$	9,037,091		$	80,892,674	$	89,929,765
Intersegment net revenues *	$	901,250		$	—	$	901,250
(Loss) Income from operations	$	(3,410,189	)	$	20,507,804	$	17,097,615
Depreciation and amortization	$	264,830		$	3,816,857	$	4,081,687
Compensatory element of stock issuances	$	83,277		$	—	$	83,277
Total identifiable assets	$	24,592,582		$	164,913,613	$	189,506,195
Capital expenditures	$	291,294		$	3,405,502	$	3,696,796

* Amounts eliminated in consolidation

Export Product Sales

The Company’s areas of operations are principally in the United States. The Company had export sales of medical equipment amounting to 48.9% and 69.3% of product sales revenues to third parties for the years ended June 30, 2022 and 2021, respectively.

Export Product Sales

The foreign product sales, as a percentage of product sales to unrelated parties, were made to customers in the following countries:

	For the Years Ended June 30
	2022			2021
Dominican Republic		12.0	%		67.0	%
Canada		0.6	%		0.1	%
Germany		—			2.1	%
Puerto Rico		36.3	%		0.1	%
		48.9	%		69.3	%

Foreign Service and Repair Fees

The Company’s areas of service and repair are principally in the United States. The Company had foreign revenues of service and repair of medical equipment amounting to 4.4% and 4.5% of consolidated net service and repair fees for the years ended June 30, 2022 and 2021 respectively. Foreign service and repair fees, as a percentage of total service and repair fees, were provided principally to the following countries:

 Foreign Service and Repair Fees

	For the Years Ended June 30,
	2022			2021
Puerto Rico		1.5	%		1.5
Switzerland		0.3			0.3
Germany		1.6			1.5
England		0.6			0.6
Canada		—			0.3
Greece		0.3			0.3
Australia		0.1			—
		4.4	%		4.5